Share This Article
When my nephew turned 11, his pediatrician mentioned it was time for his first meningitis vaccine, and I realized I didn’t know there were multiple types or why the schedule includes a booster years later. That conversation sent me digging into the CDC’s actual recommendations, which turned out to be more nuanced than “get the shot once and you’re covered.” This guide breaks down what the meningitis vaccine protects against, who needs which type, and when boosters matter, based on current CDC guidance.
Three types of meningitis vaccine are used in the U.S. MenACWY, MenB, and the newer combination MenABCWY, each protecting against different serogroups of meningococcal bacteria. The CDC recommends a MenACWY meningitis vaccine at age 11–12 with a booster at 16, while MenB vaccination is typically a shared decision between ages 16–23 or given to those at increased risk.
What Does the Meningitis Vaccine Actually Protect Against?
It protects against meningococcal disease, a serious bacterial infection that can cause meningitis and bloodstream infections.
It specifically targets Neisseria meningitidis, the bacteria responsible for meningococcal disease. According to the CDC, meningococcal disease is uncommon but can cause serious illness and death in people of all ages, which is why vaccination is recommended despite the relative rarity of cases. It’s worth noting that “meningitis” can also be caused by viruses or other bacteria not covered by this particular meningitis vaccine, so it protects against one important but specific cause.
What Are the Different Types?
The three types used in the U.S. are MenACWY (covering serogroups A, C, W, Y), MenB (covering serogroup B), and MenABCWY (a newer combination covering all five).
Understanding which vaccine covers which serogroups matters because none of them cover every strain on their own:
- MenACWY – protects against serogroups A, C, W, and Y; part of the routine adolescent schedule
- MenB – protects against serogroup B; typically a shared clinical decision for ages 16–23
- MenABCWY – a newer pentavalent meningitis vaccine covering all five serogroups (A, B, C, W, Y) in fewer shots
According to the CDC, each type protects against different serogroups of meningococcal disease, which is why a healthcare provider needs to consider age, risk factors, and prior vaccination history when deciding which meningitis vaccine — or combination — is appropriate.
When Should Preteens and Teens Get the Meningitis Vaccine?
The CDC recommends the first dose of MenACWY meningitis vaccine at age 11–12, with a booster dose at age 16.
The standard adolescent schedule is one of the more straightforward parts of meningitis vaccine guidance. According to the CDC, all 11- to 12-year-olds should receive a MenACWY vaccine, with a booster recommended at age 16 since protection wanes over time. If the initial meningitis vaccine was delayed and given between ages 13–15, a booster is still recommended at 16–18; if the first dose was given at 16 or older, no booster is needed. The 16-year booster matters because it protects during the college-age years, when meningococcal disease risk is elevated.
Is the MenB Meningitis Vaccine Recommended for Everyone?
MenB vaccination is a shared clinical decision for healthy teens aged 16–23, but it’s specifically recommended for people at increased risk regardless of age.
Unlike MenACWY, the MenB meningitis vaccine isn’t part of the universal adolescent schedule. According to the CDC, MenB vaccines are recommended for adults identified as being at increased risk, such as during a serogroup B outbreak, or for those with specific medical conditions like functional or anatomic asplenia. For healthy teens without elevated risk, the decision to get this particular meningitis vaccine is typically made collaboratively between the patient, parents, and healthcare provider — commonly called “shared clinical decision-making.”
Who Is Considered at Increased Risk and Needs Extra Meningitis Vaccine Doses?
People with complement deficiencies, those on complement inhibitor medications, individuals with asplenia, and some travelers or lab workers need additional protection.
Certain groups need a more intensive meningitis vaccine schedule than the standard adolescent series. According to the CDC, patients aged 2 years or older in specific high-risk situations should receive a 2-to-4-dose primary series along with regular booster doses for as long as they remain at increased risk. For those who received their most recent dose before age 7, a booster is recommended three years later; for those age 7 or older at their most recent dose, the booster comes five years later, repeating every five years while risk persists.
What Is the Newer Combination Meningitis Vaccine (MenABCWY)?
MenABCWY is a pentavalent meningitis vaccine that combines MenACWY and MenB protection into one product, reducing the number of shots needed.
The newest addition to meningitis vaccine options streamlines protection against all five major serogroups. According to CDC’s Advisory Committee on Immunization Practices (ACIP), a second pentavalent MenABCWY vaccine was licensed in February 2025, and ACIP recommended it may be used when both MenACWY and MenB vaccination are indicated at the same visit — either for healthy 16-to-23-year-olds choosing MenB vaccination, or for people 10 and older at increased risk for meningococcal disease. This combination meningitis vaccine option can simplify scheduling for people who need both types of protection.
What Side Effects Can Occur After a Meningitis Vaccine?
Most side effects are mild and short-lived, including soreness at the injection site, fatigue, and headache lasting a few days.
Side effects from any meningitis vaccine are typically manageable and temporary. According to the CDC, if problems occur after MenB or MenABCWY vaccination specifically, they usually last three to five days. As with any vaccine, serious reactions are rare, and healthcare providers can address specific concerns based on a person’s medical history before administering any meningitis vaccine.
Should Pregnant or Breastfeeding Women Get a Meningitis Vaccine?
MenACWY may be appropriate for pregnant women at increased risk, while MenB and MenABCWY are generally deferred during pregnancy unless a provider determines the benefit outweighs the risk.
Pregnancy adds an important layer of nuance to meningitis vaccine decisions. According to the CDC, women at increased risk for serogroup A, C, W, or Y disease who are pregnant may receive MenACWY vaccines, while healthcare providers generally defer MenB and MenABCWY vaccination during pregnancy. Breastfeeding women at increased risk for serogroup B disease may receive MenB vaccines after discussing the benefits and risks with a provider.
How Often Do Meningitis Vaccine Booster Doses Need to Be Repeated?
For those at ongoing increased risk, MenACWY boosters are typically needed every five years for as long as the risk factor persists.
Booster timing depends heavily on individual risk status rather than a single universal rule. According to the Merck Manual, revaccination with MenACWY every five years is recommended for adults previously vaccinated who remain at increased risk of infection. This is different from the routine adolescent schedule, which typically ends after the age-16 booster for people without ongoing risk factors — another reason discussing your specific meningitis vaccine history with a provider matters more than following a generic timeline.
Frequently Asked Questions
Is one meningitis vaccine enough for lifetime protection?
Not necessarily. Protection can wane over time, which is why boosters are recommended at age 16 for the general adolescent schedule, and every five years for those at ongoing increased risk.
Can you get MenACWY and MenB meningitis vaccines at the same visit?
Yes. They can be given together, or a combination MenABCWY vaccine may be used instead when both are indicated at the same visit.
Do college students need a meningitis vaccine?
Many colleges require proof of MenACWY vaccination, and the age-16 booster is specifically timed to provide protection during these higher-risk young adult years.
Conclusion
The meningitis vaccine landscape has become more nuanced with the addition of MenB and combination MenABCWY options, but the core guidance remains clear: MenACWY at 11–12 with a booster at 16 covers most adolescents, while MenB and additional doses depend on individual risk factors. If you’re unsure which meningitis vaccine schedule applies to you or your child, a conversation with a healthcare provider about age, risk factors, and vaccination history is the most reliable way to get a clear answer. This content is educational and not a substitute for personalized medical advice.
